The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R).
 
Patrick M. Forde
Consulting or Advisory Role - Amgen; Ascendis Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; CureVac; Daiichi Sankyo/UCB Japan; F-Star Biotechnology; Fosun Pharma; G1 Therapeutics; Genentech; Gilead Sciences; ITeos Therapeutics; Janssen; Merck; Novartis; Regeneron; Sanofi; Surface Oncology; Synthekine; Teva
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals; Kyowa Hakko Kirin (Inst); Novartis (Inst); Regeneron
 
Anna K. Nowak
Consulting or Advisory Role - Atara biotherapeutics; Bayer; Boehringer Ingelheim; Douglas pharmaceuticals; Merck Sharp & Dohme; Pharmabcine; Roche; Seagen; Trizell
Research Funding - AstraZeneca (Inst); Douglas Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Aventis; Takeda
Research Funding - Amgen (Inst)
 
Peey Sei Kok
Honoraria - AstraZeneca/MedImmune; Pfizer
Consulting or Advisory Role - MSD
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - AstraZeneca (Inst); Roche (Inst)
 
Chris Brown
No Relationships to Disclose
 
Zhuoxin Sun
No Relationships to Disclose
 
Valsamo Anagnostou
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Delfi Diagnostics (Inst); Personal Genome Diagnostics (Inst)
 
Ken O'Byrne
Stock and Other Ownership Interests - Carpe Vitae Pharmaceuticals; DGC Diagnostics; RepLuca Pharmaceuticals
Honoraria - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Takeda; TriStar Technology Group; Yuhan
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck; Merck Sharp & Dohme; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - I am named on 4 active patents, 2 published and 2 provisional (Inst)
 
Sonia Yip
No Relationships to Disclose
 
Alistair Cook
No Relationships to Disclose
 
Willem Joost Lesterhuis
Stock and Other Ownership Interests - Setonix Pharmaceuticals
Consulting or Advisory Role - Axelia Oncology (Inst); Douglas Pharmaceuticals (Inst)
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Telethon Kids Institute (Inst)
 
Nick Pavlakis
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck KGaA; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - Bayer (Inst); Pfizer (Inst); Roche (Inst)
 
Julie R. Brahmer
Honoraria - Janssen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; GlaxoSmithKline; Incyte; Merck; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); RAPT Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Other Relationship - Bristol-Myers Squibb; Merck; Regeneron
 
Hedy L. Kindler
Consulting or Advisory Role - AstraZeneca; Bluestar Genomics; Deciphera; Inhibrx; Sanofi; Seagen; Tempus
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Deciphera (Inst); Fibrogen (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Inhibrx (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Polaris (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst); Verastem (Inst); Vivace Therapeutics (Inst)
 
Anne S. Tsao
Consulting or Advisory Role - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Epizyme; Genentech/Roche; HERON; Lilly; Novartis; Takeda
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Merck; Millennium; Polaris; Seagen; Seagen; Takeda
Patents, Royalties, Other Intellectual Property - UptoDate
 
Marjorie Glass Zauderer
Honoraria - Medscape; PER
Consulting or Advisory Role - Curis; Ikena Oncology
Research Funding - Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst)
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Suresh S. Ramalingam
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
Other Relationship - American Cancer Society
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tilray (Inst)